Biohaven Ownership | Who Owns Biohaven?
Biohaven Ownership Summary
Biohaven is owned by 30.51% institutional investors, 11.70% insiders, and 57.79% retail investors. Vanguard group is the largest institutional shareholder, holding 8.92% of BHVN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.48% of its assets in Biohaven shares.
BHVN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Biohaven | 30.51% | 11.70% | 57.79% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 8.41M | 8.92% | $314.27M |
Blackrock funding, inc. /de | 7.67M | 8.12% | $286.37M |
Blackrock | 6.17M | 7.56% | $214.15M |
Janus henderson group | 6.98M | 7.40% | $260.73M |
Stifel financial | 6.56M | 6.95% | $244.99M |
Suvretta capital management | 5.62M | 5.96% | $209.92M |
Farallon capital management | 4.43M | 4.69% | $165.39M |
State street | 3.51M | 3.72% | $131.19M |
Price t rowe associates inc /md/ | 3.41M | 3.62% | $127.45M |
Rp management | 2.94M | 3.11% | $146.74M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rp management | 2.94M | 64.43% | $146.74M |
Oracle investment management | 851.77K | 17.32% | $31.81M |
Suvretta capital management | 5.62M | 7.15% | $209.92M |
Boone capital management | 361.42K | 4.55% | $13.50M |
Lion point capital, lp | 22.70K | 4.44% | $847.85K |
5am venture management | 478.97K | 4.27% | $17.89M |
Ars investment partners | 1.04M | 3.50% | $38.87M |
Bison wealth | 332.43K | 2.74% | $12.42M |
Altium capital management lp | 250.00K | 2.65% | $9.34M |
Redmile group | 904.50K | 2.35% | $33.78M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Jpmorgan chase | 1.98M | 0.01% | 1.17M |
Norges bank | 902.57K | 0.00% | 902.57K |
Blackrock funding, inc. /de | 7.67M | 0.01% | 789.83K |
Farallon capital management | 4.43M | 0.84% | 785.58K |
Janus henderson group | 6.98M | 0.13% | 756.03K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perceptive advisors | - | - | -1.49M |
Darwin global management | - | - | -1.48M |
T. rowe price investment management | - | - | -1.23M |
Adage capital partners gp | 575.00K | 0.04% | -907.49K |
Point72 asset management | 922.97K | 0.08% | -577.32K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 902.57K | 0.00% | 902.57K | $33.71M |
Pfizer | 505.64K | 0.73% | 505.64K | $18.89M |
Pfm health sciences, lp | 431.92K | 1.00% | 431.92K | $16.13M |
Boone capital management | 361.42K | 4.55% | 361.42K | $13.50M |
Emerald advisers | 360.54K | 0.52% | 360.54K | $13.47M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Allspring global investments | -2.00 |
Principal securities | -3.00 |
Tfc financial management | -3.00 |
Gps wealth strategies group | -5.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 107 | -59.62% | 28,793,137 | -66.29% | 30 | 0.37% | 63 | -53.33% | 20 | -73.68% |
Sep 30, 2024 | 263 | 11.91% | 85,395,678 | 3.25% | 90 | 1.02% | 133 | -5.00% | 76 | 43.40% |
Jun 30, 2024 | 233 | -11.74% | 82,690,329 | 11.42% | 101 | 1.23% | 139 | 6.11% | 51 | -30.14% |
Mar 31, 2024 | 264 | 14.29% | 74,214,259 | 2.75% | 90 | 0.88% | 131 | -2.24% | 73 | 46.00% |
Dec 31, 2023 | 231 | 17.26% | 72,225,057 | 16.64% | 101 | 1.23% | 134 | 63.41% | 50 | -28.57% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.53M | 2.48% | 2.02K |
Vanguard US Total Market Shares ETF | 2.43M | 2.38% | 217.08K |
iShares Russell 2000 ETF | 2.26M | 2.22% | -19.58K |
Vanguard Small Cap Index | 2.07M | 2.02% | 1.68K |
BB Biotech AG Ord | 2.04M | 2.02% | - |
T. Rowe Price Health Sciences | 1.78M | 1.74% | -36.20K |
T. Rowe Price Integrated US SmCapGrEq | 1.48M | 1.46% | 738.72K |
SPDR® S&P Biotech ETF | 1.47M | 1.44% | -15.71K |
Vanguard Small Cap Value Index Inv | 1.36M | 1.33% | -4.63K |
Fidelity Select Biotechnology | 1.33M | 1.31% | -55.60K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $759.65K |
Mar 04, 2025 | CHILDS JOHN W | - | Buy | $27.65K |
Apr 22, 2024 | CHILDS JOHN W | - | Buy | $3.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 4 | - |
2024 Q4 | 3 | - |
2024 Q3 | 2 | - |
2024 Q2 | 10 | - |
2024 Q1 | - | - |
BHVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools